A9L-25981-45279
4 vaccinations
1 coded response
16 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 201 / VA
- Registered
- 2021-01-31
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-30
Dose 1 — Pfizer-BioNTech
-
2021-01-31
Registered in v-safe
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-06
- 2021-02-13
-
2021-02-20
Dose 2 — Pfizer-BioNTech
-
2021-02-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness · Fatigue or tirednessAdult check-in
-
2021-02-27
Health check-in — day 7, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-03-07
- 2021-03-13
- 2021-03-20
- 2021-05-24
-
2021-08-21
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: New health condition: Pregnancy.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-10-30
Dose 3 — Pfizer-BioNTech
- 2022-02-20
-
2022-05-04
Dose 4 — Pfizer-BioNTech
- 2022-11-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-30 | Pfizer-BioNTech | |
| 2 | 2021-02-20 | Pfizer-BioNTech | |
| 3 | 2021-10-30 | Pfizer-BioNTech | No |
| 4 | 2022-05-04 | Pfizer-BioNTech | No |
Free text
Release 9 — 6 months, dose 2
Symptoms: New health condition: Pregnancy.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release